Patent | Date |
---|
Development Of Dengue Virus Vaccine Components App 20220251521 - Whitehead; Stephen S. ;   et al. | 2022-08-11 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 11,400,150 - Pletnev , et al. August 2, 2 | 2022-08-02 |
Development of dengue virus vaccine components Grant 11,332,722 - Whitehead , et al. May 17, 2 | 2022-05-17 |
Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein Grant 11,318,196 - Whitehead , et al. May 3, 2 | 2022-05-03 |
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production App 20210330782 - Collins; Peter L. ;   et al. | 2021-10-28 |
Genetically stable live attenuated respiratory syncytial virus vaccine and its production Grant 10,980,872 - Collins , et al. April 20, 2 | 2021-04-20 |
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus App 20210069317 - Pletnev; Alexander G. ;   et al. | 2021-03-11 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 10,869,920 - Pletnev , et al. December 22, 2 | 2020-12-22 |
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 App 20200392469 - Whitehead; Stephen S. ;   et al. | 2020-12-17 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Grant 10,837,003 - Whitehead , et al. November 17, 2 | 2020-11-17 |
Development Of Dengue Virus Vaccine Components App 20200318083 - Whitehead; Stephen S. ;   et al. | 2020-10-08 |
Development of dengue virus vaccine components Grant 10,724,007 - Whitehead , et al. | 2020-07-28 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae App 20200147202 - Whitehead; Stephen S. ;   et al. | 2020-05-14 |
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20200085939 - Whitehead; Stephen S. ;   et al. | 2020-03-19 |
Live attenuated virus vaccines for La Crosse virus and other bunyaviridae Grant 10,561,724 - Whitehead , et al. Feb | 2020-02-18 |
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile App 20200030435 - Pletnev; Alexander G. ;   et al. | 2020-01-30 |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant 10,500,264 - Whitehead , et al. Dec | 2019-12-10 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 10,456,461 - Pletnev , et al. Oc | 2019-10-29 |
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production App 20190282690 - Collins; Peter L. ;   et al. | 2019-09-19 |
Genetically stable live attenuated respiratory syncytial virus vaccine and its production Grant 10,307,476 - Collins , et al. | 2019-06-04 |
Development Of Dengue Virus Vaccine Components App 20190119654 - Whitehead; Stephen S. ;   et al. | 2019-04-25 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae App 20190117762 - Whitehead; Stephen S. ;   et al. | 2019-04-25 |
Live attenuated virus vaccines for la crosse virus and other bunyaviridae Grant 10,206,995 - Whitehead , et al. Feb | 2019-02-19 |
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus App 20180369358 - Pletnev; Alexander G. ;   et al. | 2018-12-27 |
Development of dengue virus vaccine components Grant 10,160,957 - Whitehead , et al. Dec | 2018-12-25 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 10,058,602 - Pletnev , et al. August 28, 2 | 2018-08-28 |
Development Of Dengue Virus Vaccine Components App 20180171308 - Whitehead; Stephen S. ;   et al. | 2018-06-21 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae App 20180104326 - Whitehead; Stephen S. ;   et al. | 2018-04-19 |
Live attenuated virus vaccines for la crosse virus and other bunyaviridae Grant 9,884,104 - Whitehead , et al. February 6, 2 | 2018-02-06 |
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1, 2, 3, And 4, Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4 App 20180010099 - Whitehead; Stephen S. ;   et al. | 2018-01-11 |
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20180008693 - Whitehead; Stephen S. ;   et al. | 2018-01-11 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Grant RE46,641 - Whitehead , et al. December 19, 2 | 2017-12-19 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Grant RE46,631 - Whitehead , et al. December 12, 2 | 2017-12-12 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Grant 9,783,787 - Whitehead , et al. October 10, 2 | 2017-10-10 |
Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein Grant 9,707,287 - Whitehead , et al. July 18, 2 | 2017-07-18 |
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production App 20170189520 - Collins; Peter L. ;   et al. | 2017-07-06 |
Genetically stable live attenuated respiratory syncytial virus vaccine and its production Grant 9,624,475 - Collins , et al. April 18, 2 | 2017-04-18 |
Apparatus,system And Method Of Geofencing App 20170034656 - Wang; Zhi Gang ;   et al. | 2017-02-02 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae App 20160367657 - Whitehead; Stephen S. ;   et al. | 2016-12-22 |
Development of dengue virus vaccine components Grant RE46,042 - Whitehead , et al. June 28, 2 | 2016-06-28 |
Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae Grant 9,255,252 - Whitehead , et al. February 9, 2 | 2016-02-09 |
Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses Grant 9,238,799 - Pletnev , et al. January 19, 2 | 2016-01-19 |
Development of dengue virus vaccine components Grant 9,090,873 - Whitehead , et al. July 28, 2 | 2015-07-28 |
Attenuated human parainfluenza virus, methods and uses thereof Grant 9,034,343 - Skiadopoulos , et al. May 19, 2 | 2015-05-19 |
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production App 20150118732 - Collins; Peter L. ;   et al. | 2015-04-30 |
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20150064214 - Whitehead; Stephen S. ;   et al. | 2015-03-05 |
Detection of boilerplate content Grant 8,898,296 - Zeng , et al. November 25, 2 | 2014-11-25 |
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus App 20140294892 - Pletnev; Alexander G. ;   et al. | 2014-10-02 |
Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis Grant RE45,123 - Whitehead , et al. September 9, 2 | 2014-09-09 |
Attenuated dengue virus comprising mutations in the NS3 gene Grant RE45,053 - Whitehead , et al. July 29, 2 | 2014-07-29 |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant RE45,016 - Whitehead , et al. July 15, 2 | 2014-07-15 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 8,778,671 - Pletnev , et al. July 15, 2 | 2014-07-15 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae App 20140023679 - Whitehead; Stephen S. ;   et al. | 2014-01-23 |
Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3' untranslated region Grant 8,632,782 - Whitehead , et al. January 21, 2 | 2014-01-21 |
Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses App 20140004147 - Pletnev; Alexander G. ;   et al. | 2014-01-02 |
Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses Grant 8,568,739 - Pletnev , et al. October 29, 2 | 2013-10-29 |
Development Of Dengue Virus Vaccine Components App 20130089567 - Whitehead; Stephen S. ;   et al. | 2013-04-11 |
Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens Grant 8,367,074 - Skiadopoulos , et al. February 5, 2 | 2013-02-05 |
Recovery Of Recombinant Human Parainfluenza Virus Type 2 (hypiv2) From Cdna And Use Of Recombinant Hpiv2 In Immunogenic Compositions And As Vectors To Elicit Immune Responses Against Piv And Other Human Pathogens App 20130023030 - SKIADOPOULOS; Mario H. ;   et al. | 2013-01-24 |
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1, 2, 3, And 4, Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4 App 20130011433 - Whitehead; Stephen S. ;   et al. | 2013-01-10 |
Development of dengue virus vaccine components Grant 8,337,860 - Whitehead , et al. December 25, 2 | 2012-12-25 |
Detection Of Boilerplate Content App 20120297025 - Zeng; Jian ;   et al. | 2012-11-22 |
Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae Grant 8,298,541 - Whitehead , et al. October 30, 2 | 2012-10-30 |
Neutralizing monoclonal antibodies to respiratory syncytial virus Grant 8,221,759 - Pilkington , et al. July 17, 2 | 2012-07-17 |
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20120114694 - Whitehead; Stephen S. ;   et al. | 2012-05-10 |
Hexavalent bovine rotavirus reassortant composition designed for use in developing countries Grant 8,168,202 - Kapikian , et al. May 1, 2 | 2012-05-01 |
Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus App 20120087909 - Pilkington; Glenn R. ;   et al. | 2012-04-12 |
Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses App 20120076821 - Pletnev; Alexander G. ;   et al. | 2012-03-29 |
Production Of Attenuated Negative Stranded Rna Virus Vaccines From Cloned Nucleotide Sequences App 20120064569 - Murphy; Brian R. ;   et al. | 2012-03-15 |
System And Method For Modifying An Article And A Modified Article App 20110308610 - MURPHY; Brian R. | 2011-12-22 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 Grant 8,075,903 - Whitehead , et al. December 13, 2 | 2011-12-13 |
Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis Grant 8,039,003 - Whitehead , et al. October 18, 2 | 2011-10-18 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae App 20110200630 - Whitehead; Stephen S. ;   et al. | 2011-08-18 |
RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1 App 20110189232 - Bartlett; Emmalene ;   et al. | 2011-08-04 |
Recovery Of Recombinant Human Parainfluenza Virus Type 2 (hypiv2) From Cdna And Use Of Recombinant Hpiv2 In Immunogenic Compositions And As Vectors To Elicit Immune Responses Against Piv And Other Human Pathogens App 20110143422 - SKIADOPOULOS; Mario H. ;   et al. | 2011-06-16 |
Attenuated parainfluenza virus (PIV) vaccines Grant 7,951,383 - Murphy , et al. May 31, 2 | 2011-05-31 |
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens Grant 7,919,301 - Skiadopoulos , et al. April 5, 2 | 2011-04-05 |
Human Parainfluenza Viruses Having Separated P And C Genes App 20100330120 - Collins; Peter L. ;   et al. | 2010-12-30 |
Chimeric Sle/dengue Type 4 Antigenic Viruses App 20100316670 - Blaney; Joseph E. ;   et al. | 2010-12-16 |
Attenuated chimeric respiratory syncytial virus Grant 7,846,455 - Collins , et al. December 7, 2 | 2010-12-07 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines Grant 7,842,798 - Buchholz , et al. November 30, 2 | 2010-11-30 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines Grant 7,829,102 - Buchholz , et al. November 9, 2 | 2010-11-09 |
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens Grant 7,820,181 - Skiadopoulos , et al. October 26, 2 | 2010-10-26 |
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions Grant 7,820,182 - Buchholz , et al. October 26, 2 | 2010-10-26 |
Safe code-motion of dangerous instructions during compiler optimization Grant 7,810,086 - Murphy , et al. October 5, 2 | 2010-10-05 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes Grant 7,744,902 - Krempl , et al. June 29, 2 | 2010-06-29 |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences Grant 7,709,007 - Murphy , et al. May 4, 2 | 2010-05-04 |
Development Of Dengue Virus Vaccine Components App 20100104598 - Whitehead; Stephen S. ;   et al. | 2010-04-29 |
Recombinant human metapneumovirus and its use Grant 7,704,491 - Collins , et al. April 27, 2 | 2010-04-27 |
Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens Grant 7,704,509 - Murphy , et al. April 27, 2 | 2010-04-27 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes Grant 7,662,397 - Krempl , et al. February 16, 2 | 2010-02-16 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines Grant 7,632,508 - Schmidt , et al. December 15, 2 | 2009-12-15 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines Grant 7,622,123 - Skiadopoulos , et al. November 24, 2 | 2009-11-24 |
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20090263424 - Whitehead; Stephen S. ;   et al. | 2009-10-22 |
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3' -utr Of Dengue Types 1, 2, 3, And 4 Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4 App 20090258036 - Whitehead; Stephen S. ;   et al. | 2009-10-15 |
Attenuated dengue virus comprising mutations in the NS3 gene Grant 7,560,118 - Whitehead , et al. July 14, 2 | 2009-07-14 |
Neutralizing monoclonal antibodies to respiratory syncytial virus App 20090110684 - Pilkington; Glenn R. ;   et al. | 2009-04-30 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Grant 7,517,531 - Whitehead , et al. April 14, 2 | 2009-04-14 |
Production Of Attenuated Negative Stranded Rna Virus Vaccines From Cloned Nucleotide Sequences App 20090081728 - Murphy; Brian R. ;   et al. | 2009-03-26 |
Neutralizing monoclonal antibodies to respiratory syncytial virus Grant 7,488,477 - Pilkington , et al. February 10, 2 | 2009-02-10 |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 Grant 7,485,440 - Collins , et al. February 3, 2 | 2009-02-03 |
Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules Grant 7,465,794 - Collins , et al. December 16, 2 | 2008-12-16 |
Hexavalent Bovine Rotavirus Reassortant Composition Designed for Use in Developing Countries App 20080292660 - Kapikian; Albert Z. ;   et al. | 2008-11-27 |
RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS App 20080286848 - SKIADOPOULOS; Mario H. ;   et al. | 2008-11-20 |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 App 20080138861 - Collins; Peter L. ;   et al. | 2008-06-12 |
Human neutralizing monoclonal antibodies to respiratory syncytial virus Grant 7,364,737 - Burton , et al. April 29, 2 | 2008-04-29 |
Attenuated parainfluenza virus (PIV) vaccines App 20080096264 - Murphy; Brian R. ;   et al. | 2008-04-24 |
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV) Grant 7,314,631 - Murphy , et al. January 1, 2 | 2008-01-01 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines App 20070184069 - Buchholz; Ursula ;   et al. | 2007-08-09 |
Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein Grant 7,250,171 - Tao , et al. July 31, 2 | 2007-07-31 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines App 20070134271 - Skiadopoulos; Mario H. ;   et al. | 2007-06-14 |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant 7,226,602 - Whitehead , et al. June 5, 2 | 2007-06-05 |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses App 20070092534 - Whitehead; Stephen S. ;   et al. | 2007-04-26 |
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences Grant 7,208,161 - Murphy , et al. April 24, 2 | 2007-04-24 |
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines Grant 7,201,907 - Schmidt , et al. April 10, 2 | 2007-04-10 |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens Grant 7,192,593 - Murphy , et al. March 20, 2 | 2007-03-20 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 App 20070009552 - Whitehead; Stephen S. ;   et al. | 2007-01-11 |
Safety verification of computer program App 20070006197 - Murphy; Brian R. ;   et al. | 2007-01-04 |
Safe code-motion of dangerous instructions during compiler optimization App 20070006187 - Murphy; Brian R. ;   et al. | 2007-01-04 |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences App 20060159703 - Murphy; Brian R. ;   et al. | 2006-07-20 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines App 20060099226 - Schmidt; Alexander C. ;   et al. | 2006-05-11 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines App 20060057158 - Buchholz; Ursula ;   et al. | 2006-03-16 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes App 20060024797 - Krempl; Christine D. ;   et al. | 2006-02-02 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes App 20060018927 - Krempl; Christine D. ;   et al. | 2006-01-26 |
Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences App 20050287540 - Murphy, Brian R. ;   et al. | 2005-12-29 |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules App 20050220767 - Collins, Peter L. ;   et al. | 2005-10-06 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes Grant 6,923,971 - Krempl , et al. August 2, 2 | 2005-08-02 |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules App 20050147622 - Collins, Peter L. ;   et al. | 2005-07-07 |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences App 20050100557 - Collins, Peter L. ;   et al. | 2005-05-12 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus App 20050100886 - Pletnev, Alexander G. ;   et al. | 2005-05-12 |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses App 20050010043 - Whitehead, Stephen S. ;   et al. | 2005-01-13 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes App 20040258714 - Krempl, Christine D. ;   et al. | 2004-12-23 |
Recombinant human metapneumovirus and its use App 20040241188 - Collins, Peter L. ;   et al. | 2004-12-02 |
Human neutralizing monoclonal antibodies to respiratory syncytial virus App 20040234528 - Burton, Dennis R. ;   et al. | 2004-11-25 |
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immonogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens App 20040204581 - Skiadopoulos, Mario H. ;   et al. | 2004-10-14 |
Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens App 20040142448 - Murphy, Brian R. ;   et al. | 2004-07-22 |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 Grant 6,713,066 - Collins , et al. March 30, 2 | 2004-03-30 |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences Grant 6,689,367 - Collins , et al. February 10, 2 | 2004-02-10 |
Human neutralizing monoclonal antibodies to respiratory syncytial virus Grant 6,685,942 - Burton , et al. February 3, 2 | 2004-02-03 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes App 20040005542 - Krempl, Christine D ;   et al. | 2004-01-08 |
Neutralizing monoclonal antibodies to respiratory syncytial virus App 20040005324 - Pilkington, Glenn R. ;   et al. | 2004-01-08 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines App 20030082209 - Skiadopoulos, Mario H. ;   et al. | 2003-05-01 |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens App 20020155581 - Murphy, Brian R. ;   et al. | 2002-10-24 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes App 20020146433 - Krempl, Christine D. ;   et al. | 2002-10-10 |
Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene Grant 6,410,023 - Durbin , et al. June 25, 2 | 2002-06-25 |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences Grant 5,993,824 - Murphy , et al. November 30, 1 | 1999-11-30 |
Attenuated respiratory syncytial virus vaccine compositions Grant 5,922,326 - Murphy , et al. July 13, 1 | 1999-07-13 |
Attenuated respiratory syncytial virus vaccine compositions Grant 5,882,651 - Murphy , et al. March 16, 1 | 1999-03-16 |
Human neutralizing monoclonal antibodies to respiratory syncytial virus Grant 5,762,905 - Burton , et al. June 9, 1 | 1998-06-09 |
Human use of avian-human reassortants as vaccines for influenza A virus Grant 4,552,758 - Murphy , et al. November 12, 1 | 1985-11-12 |
Temperature-sensitive recombinant mutant viruses and a process for producing same Grant 3,992,522 - Chanock , et al. November 16, 1 | 1976-11-16 |